Autopsy report · NCT01800162

RCT for Women With a Persisting Pregnancy of Unknown Location

“A new protocol was written to replace this protocol.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 10 months before it stopped.
• 2 participants enrolled.
• Results were posted on the registry 3 years 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

University of Pennsylvania

Sponsor type

University, hospital or other

Conditions

Persistent Pregnancy of Unknown Location; Ectopic Pregnancy

Interventions

Methotrexate; Uterine Evacuation; Expectant Management

Participants

2

Sites

2

Countries

United States

Trials that died the same way

• Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
  “Replaced by another protocol” (85% match in meaning)
• Adjunctive Treatment With Vitamin D3 in Patients With Active IBD
  “Protocol is being modified.” (83% match in meaning)
• Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection
  “to be replaced with a different protocol” (82% match in meaning)
• A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee
  “To be replaced by a different protocol” (82% match in meaning)
• Epidural Loading: High Volume, Low Concentration
  “The protocol will be rewritten.” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.